Advertisements



The Week Ahead In Biotech: Conferences, Clinical Trials And IPOs

The ASCO conference closed Tuesday, although presentations at the conference triggered some huge stocks moves. read more.....»»

Category: blogSource: benzingaJun 10th, 2018

The Week Ahead In Biotech: Conferences, Clinical Trials, Earnings And IPOs

The earnings season hasn't panned out well for pharma companies, with Amgen, Inc. (NASDAQ: AMGN), Novartis AG (NYS.....»»

Category: earningsSource: benzingaFeb 3rd, 2019

The Week Ahead In Biotech: Conferences, Clinical Trials And IPOs

The ASCO conference closed Tuesday, although presentations at the conference triggered some huge stocks moves. read more.....»»

Category: blogSource: benzingaJun 10th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials

Biotech stocks held steady in the recent week as earnings from the sector continue to trickle in. The week also saw presentations of clinical t.....»»

Category: worldSource: nytFeb 10th, 2019

The Week Ahead In Biotech: Conferences, Clinical Trials

The new year kick started with a bumper deal in the pharma space, with Bristol-Myers Squibb Co (NYSE: BMY) agreeing to buy Celgene Corporation (NASDAQ: read more.....»»

Category: blogSource: benzingaJan 6th, 2019

The Week Ahead In Biotech: Conferences, Clinical Trials And Earnings

Biotech stocks pulled back in last week. Incidentally, some large-cap biotec.....»»

Category: blogSource: benzingaDec 8th, 2018

The Week Ahead In Biotech: Conferences, Clinical Trials And Earnings

Biotech stocks pulled back in last week. Incidentally, some large-cap .....»»

Category: smallbizSource: nytDec 8th, 2018

The Week Ahead In Biotech: ASH Presentations Pick Up Pace, PDUFA Dates, Clinical Trials And IPOs

Large-cap pharma stocks are seeing some upward momentum and are on track to f.....»»

Category: blogSource: benzingaDec 2nd, 2018

The Week Ahead In Biotech: ASH Presentations Pick Up Pace, PDUFA Dates, Clinical Trials And IPOs

Large-cap pharma stocks are seeing some upward momentum and are on track to finish the year with handsome gains. As the year draws to a close, it remains to be see.....»»

Category: personnelSource: nytDec 2nd, 2018

The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs

Biotech earnings news flow accelerated in last week, with Pfizer Inc. (NYSE: PFE) and Sanofi SA (NYSE: SNY) among the noteworthy releases of the week. With the earnin.....»»

Category: earningsSource: benzingaNov 4th, 2018

The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs

Biotech earnings news flow accelerated in last week, with Pfizer Inc. (NYSE: PFE) and Sanofi SA (NYSE: SNY) among the noteworthy releases of the week. read more.....»»

Category: blogSource: benzingaNov 4th, 2018

The Week Ahead In Biotech: Conferences, Clinical Trial Results And IPOs

As we step into the final quarter of 2018, biotech stocks have recorded double-digit gains for the year-to-date period. Will the run up continue? Stay tuned to the following events of the upcoming week. read more.....»»

Category: blogSource: benzingaOct 8th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results And IPOs

After ending almost flat in the week ended Sept. 14, biotech stocks have seen some bounce in the running week, with the iShares NASDAQ Biotechnology Index (NASDAQ: IBB) up about 1.3 percent through Thursday. read more.....»»

Category: blogSource: benzingaSep 24th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results And IPOs

After ending almost flat in the week ended Sept. 14, biotech stocks have seen.....»»

Category: earningsSource: benzingaSep 24th, 2018

The Week Ahead In Biotech (Sept. 23-29): Conferences, PDUFA Dates, Clinical Trial Results And IPOs

After ending almost flat in the week ended Sept. 14, biotech stocks have seen some bounce in the running week, with the iShares NASDAQ Biotechnology Index (NASDAQ: IBB) up about 1.3 percent through Thursday. read more.....»»

Category: blogSource: benzingaSep 23rd, 2018

The Week Ahead In Biotech (Sept. 23-29): Conferences, PDUFA Dates, Clinical Trial Results And IPOs

After ending almost flat in the week ended Sept. 14, .....»»

Category: earningsSource: benzingaSep 23rd, 2018

The Week Ahead In Biotech (Sept. 16-22): Conferences, PDUFA Dates, Clinical Trial Results And IPOs

Biotech were¬†trending mostly sideways in the week ending Sept. 14 after posting weekly gains in the previous two weeks. Notwithstanding the overall muted sentiment, there was some activity in reaction to the release of clinical trial results. read more.....»»

Category: blogSource: benzingaSep 16th, 2018

The Week Ahead In Biotech: Conferences, Clinical Trial Results, Earnings And IPOs

After recording stellar gains of 4.3 percent in the week ended Aug. 31 to close the month in the green, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) saw a moderation in momentum in the holiday-shortened week ending Sept. 7. read more.....»»

Category: blogSource: benzingaSep 9th, 2018

The Week Ahead In Biotech: Conferences, Clinical Trial Results, Earnings And IPOs

After recording stellar gains of 4.3 percent in the week ended Aug. 31 to close the month .....»»

Category: earningsSource: benzingaSep 9th, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings

The biotech sector notched strong gains last week, capitalizing on the positive overall mark.....»»

Category: earningsSource: benzingaSep 2nd, 2018

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings

The biotech .....»»

Category: blogSource: benzingaSep 2nd, 2018